{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:24:41Z","timestamp":1786119881274,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/lgt.0b013e3181fb46d8","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T14:31:29Z","timestamp":1309444289000},"page":"224-230","source":"Crossref","is-referenced-by-count":4,"title":["High-Risk HPV DNA Testing and HPV-16\/18 Genotyping"],"prefix":"10.1097","volume":"15","author":[{"given":"Leo B.","family":"Twiggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210126","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"R2-9-20210126","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective.","volume":"111","author":"Munoz","year":"2004","journal-title":"Int J Cancer"},{"key":"R3-9-20210126","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"R4-9-20210126","first-page":"9","article-title":"Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia.","volume":"14-","author":"Schiffman","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R5-9-20210126","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/cncr.22487","article-title":"Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).","volume":"111","author":"Eltoum","year":"2007","journal-title":"Cancer"},{"key":"R8-9-20210126","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.287.18.2372","article-title":"Benefits and costs of using HPV testing to screen for cervical cancer.","volume":"287","author":"Mandelblatt","year":"2002","journal-title":"JAMA"},{"key":"R9-9-20210126","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"key":"R10-9-20210126","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1158\/1055-9965.EPI-07-2865","article-title":"Human papillomavirus in cervical cancer screening: important role as biomarker.","volume":"17","author":"Boulet","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R11-9-20210126","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"R12-9-20210126","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer.","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"R13-9-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests.","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"R14-9-20210126","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","article-title":"109: Cervical cytology screening.","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R15-9-20210126","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer.","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"R16-9-20210126","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/LGT.0b013e3181a4e497","article-title":"Statement on HPV DNA test utilization.","volume":"13","author":"Solomon","year":"2009","journal-title":"J Low Genit Tract Dis"},{"key":"R18-9-20210126","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States.","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"R19-9-20210126","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: diagnosis, treatment, and prevention.","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R20-9-20210126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1309\/RNF3C01JKADQCLKP","article-title":"The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays.","volume":"127","author":"Stoler","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R21-9-20210126","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1158\/1055-9965.EPI-08-1012","article-title":"Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women.","volume":"18","author":"Trottier","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R22-9-20210126","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/aje\/kwn036","article-title":"Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.","volume":"168","author":"Koshiol","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R23-9-20210126","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women.","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"key":"R24-9-20210126","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer.","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"R25-9-20210126","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review.","volume":"12","author":"Ostor","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"R26-9-20210126","first-page":"13","article-title":"Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality.","volume":"3-","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R27-9-20210126","doi-asserted-by":"crossref","first-page":"b2569","DOI":"10.1136\/bmj.b2569","article-title":"Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.","volume":"339","author":"Castle","year":"2009","journal-title":"BMJ"},{"key":"R28-9-20210126","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R29-9-20210126","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.24075","article-title":"Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype.","volume":"124","author":"de Cremoux","year":"2009","journal-title":"Int J Cancer"},{"key":"R30-9-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/LGT.0b013e3181a4e4a8","article-title":"Commentary on: statement on HPV DNA test utilization.","volume":"13","author":"Cox","year":"2009","journal-title":"J Low Genit Tract Dis"},{"key":"R31-9-20210126","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jnci\/92.5.397","article-title":"Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial.","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R32-9-20210126","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J. Natl.","volume":"93","author":"Solomon","year":"2001","journal-title":"Cancer Inst"},{"key":"R34-9-20210126","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/JCM.01833-07","article-title":"Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media.","volume":"45","author":"Schutzbank","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R35-9-20210126","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/JCM.00824-08","article-title":"Human papillomavirus genotype specificity of Hybrid Capture 2.","volume":"46","author":"Castle","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R36-9-20210126","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1309\/E067X0L1U3CY37NW","article-title":"A comparison of a prototype PCR assay and Hybrid Capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears.","volume":"124","author":"Schiffman","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R38-9-20210126","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S1386-6532(09)70010-1","article-title":"Analytical performance of the investigational use only Cervista HPV HR test as determined by a multi-center study.","volume":"45","author":"Day","year":"2009","journal-title":"J Clin Virol"},{"key":"R40-9-20210126","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.","volume":"103","author":"Wright","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R43-9-20210126","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cncy.20038","article-title":"Image-guided ThinPrep Papanicolaou tests and cotesting with high-risk human papillomavirus in women aged 30 years and older in a low-risk private practice population.","volume":"117","author":"Ge","year":"2009","journal-title":"Cancer Cytopathol"},{"key":"R44-9-20210126","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening.","volume":"101","author":"Naucler","year":"2009","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Lower Genital Tract Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00128360-201107000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:36:04Z","timestamp":1786044964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00128360-201107000-00009"}},"subtitle":["What Is the Clinical Application?"],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/lgt.0b013e3181fb46d8","relation":{},"ISSN":["1089-2591"],"issn-type":[{"value":"1089-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}